Paz-Ares, L., & Thomas, M. (2012). Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): A double-blind, phase 3, randomised controlled trial. The lancet. Oncology, 13(3), . https://doi.org/10.1016/S1470-2045(12)70063-3
Chicago-Zitierstil (17. Ausg.)Paz-Ares, Luis, und Michael Thomas. "Maintenance Therapy with Pemetrexed Plus Best Supportive Care Versus Placebo Plus Best Supportive Care After Induction Therapy with Pemetrexed Plus Cisplatin for Advanced Non-squamous Non-small-cell Lung Cancer (PARAMOUNT): A Double-blind, Phase 3, Randomised Controlled Trial." The Lancet. Oncology 13, no. 3 (2012). https://doi.org/10.1016/S1470-2045(12)70063-3.
MLA-Zitierstil (9. Ausg.)Paz-Ares, Luis, und Michael Thomas. "Maintenance Therapy with Pemetrexed Plus Best Supportive Care Versus Placebo Plus Best Supportive Care After Induction Therapy with Pemetrexed Plus Cisplatin for Advanced Non-squamous Non-small-cell Lung Cancer (PARAMOUNT): A Double-blind, Phase 3, Randomised Controlled Trial." The Lancet. Oncology, vol. 13, no. 3, 2012, https://doi.org/10.1016/S1470-2045(12)70063-3.